BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The American Association for Homeopathic Products - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://theaahp.org
X-WR-CALDESC:Events for The American Association for Homeopathic Products
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20140309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20141102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20150308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20151101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20160313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20161106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20170312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20171105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211110T120000
DTEND;TZID=America/New_York:20211110T160000
DTSTAMP:20260625T152947
CREATED:20211004T160047Z
LAST-MODIFIED:20211118T183106Z
UID:10000082-1636545600-1636560000@theaahp.org
SUMMARY:EAS GMP Compliance Seminar
DESCRIPTION:11:00 a.m. ET • 10:00 a.m. CT • 9:00 a.m. MT • 8:00 a.m. PT • 16.00 GMT • 17.00 CET \n\n	\n\n\n\n	\n		\n	\n\n\n	\n						\n		\n\n			\n	\n	\n		\n	Summary\nWhether your company is located in the U.S. or the E.U.\, you need to be aware of regulations on “the other” side of the ocean in today’s global market. This is especially true for homeopathic drugs\, the starting materials for many of which are available only from one continent or the other. \nHow do the regulations within the supplier’s country impact your ability to import those starting materials? What are the ramifications of the end marketer’s national requirements on the export of homeopathic starting materials? \nAttend this important and timely webinar to: \n\nReceive an overview of the regulatory frameworks for homeopathic drugs in the U.S. and E.U.;\nUnderstand the fundamental differences between the U.S. and E.U. regulatory requirements; and\nGain insights into what you need to know for importing and exporting homeopathic drugs between the U.S. and E.U.\n\nThis one-hour webinar will introduce your company to the myriad of aspects every company needs to consider in today’s international marketplace. Presented by two established experts in the field\, this webinar will provide companies with the framework to understand the differences and comparisons between the U.S. and E.U. regulatory requirements\, as well as the impact of “the other” on your company’s suppliers and markets. The webinar will also provide an awareness of the differences between the various national pharmacopeias and why an ignorance of “the other” can lead to your products being deemed as misbranded or adulterated. \n\n	\n\n\n	\n		\n	Presenters\nSteve Mann\, Director of External Global Regulatory Affairs & QPPV\, Nelsons\n\nSteve has worked with Nelsons for more than 15 years with 20 years experience in the field of global regulation for homoeopathic drugs\, cosmetics\, herbal and dietary supplements\, and medical devices. He has worked on and managed regulatory and compliance projects in North\, Central and South America\, Europe\, North and East Africa\, Asia\, and Australasia. \nSteve currently holds board positions with various industry trade bodies\, including the British Association of Homeopathic Manufacturers (BAHM)\, the European Coalition on Homeopathic and Anthroposophic Medicinal Products (ECHAMP)\, and the U.K. Health Food Manufacturers Association (HFMA). He is also a Member of the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) and sits on the Standards and Controls and Monograph Review Committees\, and the Council on Pharmacy. \nEric Foxman\, Consultant and Board Member\, HPCUS\nEric has a rich history of work in the homeopathic industry. He has been a member of the Homeopathic Pharmacopeia Convention of the United States since its founding in 1980 and is presently in his 12th year on the Board of Trustees. Eric serves as the Senior Scientist of the Convention and the Chair of the Council on Pharmacy. In these capacities\, Eric is very active in the on-going revision and updating of the contents of the HPUS. \nEric has been active a member or representative of the American Association of Homeopathic Pharmacists for over 38 years. He has presented numerous workshops on legal\, regulatory and technical aspects of the manufacturing and marketing of homeopathic drug products. He also presents updates to the HPUS through an annual webinar. Eric is a consultant to the homeopathic industry with a focus on helping companies achieve compliance with the myriad of regulatory requirements for companies’ high-quality\, well-formulated homeopathic drug products. \n\n	\n\n\n	\n		\n	Who Should Attend?\n\nAmerican companies purchasing homeopathic materials from Europe\nEuropean companies shipping homeopathic materials into the U.S.\nAmerican companies exporting or interested in exporting homeopathic products to Europe\nEuropean companies importing American homeopathic products\nCompliance managers\nPurchasing managers\nQuality managers\nThose responsible for import/export\n\n\n	\n\n\n	\n		\n	Cost\nNonmembers: $239\nAAHP Members: $149 (With $90 discount available from the AAHP office) \n  \n\n	\n\n\n	\n		\n	\n		Register Today!\n		\n	\n	\n		\n			\n							Click Here to Register
URL:https://theaahp.org/event/eas-gmp-compliance-seminar/
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210506T130000
DTEND;TZID=America/New_York:20210506T140000
DTSTAMP:20260625T152947
CREATED:20210129T203558Z
LAST-MODIFIED:20210413T130634Z
UID:10000078-1620306000-1620309600@theaahp.org
SUMMARY:2020-21 HPUS Update Webinar
DESCRIPTION:11:00 a.m. ET • 10:00 a.m. CT • 9:00 a.m. MT • 8:00 a.m. PT • 16.00 GMT • 17.00 CET \n\n	\n\n\n\n	\n		\n	\n\n\n	\n						\n		\n\n			\n	\n	\n		\n	Summary\nWhether your company is located in the U.S. or the E.U.\, you need to be aware of regulations on “the other” side of the ocean in today’s global market. This is especially true for homeopathic drugs\, the starting materials for many of which are available only from one continent or the other. \nHow do the regulations within the supplier’s country impact your ability to import those starting materials? What are the ramifications of the end marketer’s national requirements on the export of homeopathic starting materials? \nAttend this important and timely webinar to: \n\nReceive an overview of the regulatory frameworks for homeopathic drugs in the U.S. and E.U.;\nUnderstand the fundamental differences between the U.S. and E.U. regulatory requirements; and\nGain insights into what you need to know for importing and exporting homeopathic drugs between the U.S. and E.U.\n\nThis one-hour webinar will introduce your company to the myriad of aspects every company needs to consider in today’s international marketplace. Presented by two established experts in the field\, this webinar will provide companies with the framework to understand the differences and comparisons between the U.S. and E.U. regulatory requirements\, as well as the impact of “the other” on your company’s suppliers and markets. The webinar will also provide an awareness of the differences between the various national pharmacopeias and why an ignorance of “the other” can lead to your products being deemed as misbranded or adulterated. \n\n	\n\n\n	\n		\n	Presenters\nSteve Mann\, Director of External Global Regulatory Affairs & QPPV\, Nelsons\n\nSteve has worked with Nelsons for more than 15 years with 20 years experience in the field of global regulation for homoeopathic drugs\, cosmetics\, herbal and dietary supplements\, and medical devices. He has worked on and managed regulatory and compliance projects in North\, Central and South America\, Europe\, North and East Africa\, Asia\, and Australasia. \nSteve currently holds board positions with various industry trade bodies\, including the British Association of Homeopathic Manufacturers (BAHM)\, the European Coalition on Homeopathic and Anthroposophic Medicinal Products (ECHAMP)\, and the U.K. Health Food Manufacturers Association (HFMA). He is also a Member of the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) and sits on the Standards and Controls and Monograph Review Committees\, and the Council on Pharmacy. \nEric Foxman\, Consultant and Board Member\, HPCUS\nEric has a rich history of work in the homeopathic industry. He has been a member of the Homeopathic Pharmacopeia Convention of the United States since its founding in 1980 and is presently in his 12th year on the Board of Trustees. Eric serves as the Senior Scientist of the Convention and the Chair of the Council on Pharmacy. In these capacities\, Eric is very active in the on-going revision and updating of the contents of the HPUS. \nEric has been active a member or representative of the American Association of Homeopathic Pharmacists for over 38 years. He has presented numerous workshops on legal\, regulatory and technical aspects of the manufacturing and marketing of homeopathic drug products. He also presents updates to the HPUS through an annual webinar. Eric is a consultant to the homeopathic industry with a focus on helping companies achieve compliance with the myriad of regulatory requirements for companies’ high-quality\, well-formulated homeopathic drug products. \n\n	\n\n\n	\n		\n	Who Should Attend?\n\nAmerican companies purchasing homeopathic materials from Europe\nEuropean companies shipping homeopathic materials into the U.S.\nAmerican companies exporting or interested in exporting homeopathic products to Europe\nEuropean companies importing American homeopathic products\nCompliance managers\nPurchasing managers\nQuality managers\nThose responsible for import/export\n\n\n	\n\n\n	\n		\n	Cost\nNonmembers: $239\nAAHP Members: $149 (With $90 discount available from the AAHP office) \n  \n\n	\n\n\n	\n		\n	\n		Register Today!\n		\n	\n	\n		\n			\n							Click Here to Register
URL:https://theaahp.org/event/2021-hpus-update/
CATEGORIES:Meeting,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210304T143000
DTEND;TZID=America/New_York:20210304T153000
DTSTAMP:20260625T152947
CREATED:20210108T203514Z
LAST-MODIFIED:20210226T173451Z
UID:10000077-1614868200-1614871800@theaahp.org
SUMMARY:State of Research for Homeopathy
DESCRIPTION:11:00 a.m. ET • 10:00 a.m. CT • 9:00 a.m. MT • 8:00 a.m. PT • 16.00 GMT • 17.00 CET \n\n	\n\n\n\n	\n		\n	\n\n\n	\n						\n		\n\n			\n	\n	\n		\n	Summary\nWhether your company is located in the U.S. or the E.U.\, you need to be aware of regulations on “the other” side of the ocean in today’s global market. This is especially true for homeopathic drugs\, the starting materials for many of which are available only from one continent or the other. \nHow do the regulations within the supplier’s country impact your ability to import those starting materials? What are the ramifications of the end marketer’s national requirements on the export of homeopathic starting materials? \nAttend this important and timely webinar to: \n\nReceive an overview of the regulatory frameworks for homeopathic drugs in the U.S. and E.U.;\nUnderstand the fundamental differences between the U.S. and E.U. regulatory requirements; and\nGain insights into what you need to know for importing and exporting homeopathic drugs between the U.S. and E.U.\n\nThis one-hour webinar will introduce your company to the myriad of aspects every company needs to consider in today’s international marketplace. Presented by two established experts in the field\, this webinar will provide companies with the framework to understand the differences and comparisons between the U.S. and E.U. regulatory requirements\, as well as the impact of “the other” on your company’s suppliers and markets. The webinar will also provide an awareness of the differences between the various national pharmacopeias and why an ignorance of “the other” can lead to your products being deemed as misbranded or adulterated. \n\n	\n\n\n	\n		\n	Presenters\nSteve Mann\, Director of External Global Regulatory Affairs & QPPV\, Nelsons\n\nSteve has worked with Nelsons for more than 15 years with 20 years experience in the field of global regulation for homoeopathic drugs\, cosmetics\, herbal and dietary supplements\, and medical devices. He has worked on and managed regulatory and compliance projects in North\, Central and South America\, Europe\, North and East Africa\, Asia\, and Australasia. \nSteve currently holds board positions with various industry trade bodies\, including the British Association of Homeopathic Manufacturers (BAHM)\, the European Coalition on Homeopathic and Anthroposophic Medicinal Products (ECHAMP)\, and the U.K. Health Food Manufacturers Association (HFMA). He is also a Member of the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) and sits on the Standards and Controls and Monograph Review Committees\, and the Council on Pharmacy. \nEric Foxman\, Consultant and Board Member\, HPCUS\nEric has a rich history of work in the homeopathic industry. He has been a member of the Homeopathic Pharmacopeia Convention of the United States since its founding in 1980 and is presently in his 12th year on the Board of Trustees. Eric serves as the Senior Scientist of the Convention and the Chair of the Council on Pharmacy. In these capacities\, Eric is very active in the on-going revision and updating of the contents of the HPUS. \nEric has been active a member or representative of the American Association of Homeopathic Pharmacists for over 38 years. He has presented numerous workshops on legal\, regulatory and technical aspects of the manufacturing and marketing of homeopathic drug products. He also presents updates to the HPUS through an annual webinar. Eric is a consultant to the homeopathic industry with a focus on helping companies achieve compliance with the myriad of regulatory requirements for companies’ high-quality\, well-formulated homeopathic drug products. \n\n	\n\n\n	\n		\n	Who Should Attend?\n\nAmerican companies purchasing homeopathic materials from Europe\nEuropean companies shipping homeopathic materials into the U.S.\nAmerican companies exporting or interested in exporting homeopathic products to Europe\nEuropean companies importing American homeopathic products\nCompliance managers\nPurchasing managers\nQuality managers\nThose responsible for import/export\n\n\n	\n\n\n	\n		\n	Cost\nNonmembers: $239\nAAHP Members: $149 (With $90 discount available from the AAHP office) \n  \n\n	\n\n\n	\n		\n	\n		Register Today!\n		\n	\n	\n		\n			\n							Click Here to Register
URL:https://theaahp.org/event/state-of-research-for-homeopathy/
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210304T123000
DTEND;TZID=America/New_York:20210304T134500
DTSTAMP:20260625T152947
CREATED:20210108T202430Z
LAST-MODIFIED:20210226T173430Z
UID:10000076-1614861000-1614865500@theaahp.org
SUMMARY:AAHP Annual Membership Meeting
DESCRIPTION:11:00 a.m. ET • 10:00 a.m. CT • 9:00 a.m. MT • 8:00 a.m. PT • 16.00 GMT • 17.00 CET \n\n	\n\n\n\n	\n		\n	\n\n\n	\n						\n		\n\n			\n	\n	\n		\n	Summary\nWhether your company is located in the U.S. or the E.U.\, you need to be aware of regulations on “the other” side of the ocean in today’s global market. This is especially true for homeopathic drugs\, the starting materials for many of which are available only from one continent or the other. \nHow do the regulations within the supplier’s country impact your ability to import those starting materials? What are the ramifications of the end marketer’s national requirements on the export of homeopathic starting materials? \nAttend this important and timely webinar to: \n\nReceive an overview of the regulatory frameworks for homeopathic drugs in the U.S. and E.U.;\nUnderstand the fundamental differences between the U.S. and E.U. regulatory requirements; and\nGain insights into what you need to know for importing and exporting homeopathic drugs between the U.S. and E.U.\n\nThis one-hour webinar will introduce your company to the myriad of aspects every company needs to consider in today’s international marketplace. Presented by two established experts in the field\, this webinar will provide companies with the framework to understand the differences and comparisons between the U.S. and E.U. regulatory requirements\, as well as the impact of “the other” on your company’s suppliers and markets. The webinar will also provide an awareness of the differences between the various national pharmacopeias and why an ignorance of “the other” can lead to your products being deemed as misbranded or adulterated. \n\n	\n\n\n	\n		\n	Presenters\nSteve Mann\, Director of External Global Regulatory Affairs & QPPV\, Nelsons\n\nSteve has worked with Nelsons for more than 15 years with 20 years experience in the field of global regulation for homoeopathic drugs\, cosmetics\, herbal and dietary supplements\, and medical devices. He has worked on and managed regulatory and compliance projects in North\, Central and South America\, Europe\, North and East Africa\, Asia\, and Australasia. \nSteve currently holds board positions with various industry trade bodies\, including the British Association of Homeopathic Manufacturers (BAHM)\, the European Coalition on Homeopathic and Anthroposophic Medicinal Products (ECHAMP)\, and the U.K. Health Food Manufacturers Association (HFMA). He is also a Member of the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) and sits on the Standards and Controls and Monograph Review Committees\, and the Council on Pharmacy. \nEric Foxman\, Consultant and Board Member\, HPCUS\nEric has a rich history of work in the homeopathic industry. He has been a member of the Homeopathic Pharmacopeia Convention of the United States since its founding in 1980 and is presently in his 12th year on the Board of Trustees. Eric serves as the Senior Scientist of the Convention and the Chair of the Council on Pharmacy. In these capacities\, Eric is very active in the on-going revision and updating of the contents of the HPUS. \nEric has been active a member or representative of the American Association of Homeopathic Pharmacists for over 38 years. He has presented numerous workshops on legal\, regulatory and technical aspects of the manufacturing and marketing of homeopathic drug products. He also presents updates to the HPUS through an annual webinar. Eric is a consultant to the homeopathic industry with a focus on helping companies achieve compliance with the myriad of regulatory requirements for companies’ high-quality\, well-formulated homeopathic drug products. \n\n	\n\n\n	\n		\n	Who Should Attend?\n\nAmerican companies purchasing homeopathic materials from Europe\nEuropean companies shipping homeopathic materials into the U.S.\nAmerican companies exporting or interested in exporting homeopathic products to Europe\nEuropean companies importing American homeopathic products\nCompliance managers\nPurchasing managers\nQuality managers\nThose responsible for import/export\n\n\n	\n\n\n	\n		\n	Cost\nNonmembers: $239\nAAHP Members: $149 (With $90 discount available from the AAHP office) \n  \n\n	\n\n\n	\n		\n	\n		Register Today!\n		\n	\n	\n		\n			\n							Click Here to Register
URL:https://theaahp.org/event/aahp-annual-membership-meeting/
CATEGORIES:Meeting,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210209T130000
DTEND;TZID=America/New_York:20210209T140000
DTSTAMP:20260625T152947
CREATED:20210106T150730Z
LAST-MODIFIED:20210121T143303Z
UID:10000075-1612875600-1612879200@theaahp.org
SUMMARY:Poison Control in 2021: A Complimentary Informational Webinar for Homeopathic Product Safety Stakeholders
DESCRIPTION:11:00 a.m. ET • 10:00 a.m. CT • 9:00 a.m. MT • 8:00 a.m. PT • 16.00 GMT • 17.00 CET \n\n	\n\n\n\n	\n		\n	\n\n\n	\n						\n		\n\n			\n	\n	\n		\n	Summary\nWhether your company is located in the U.S. or the E.U.\, you need to be aware of regulations on “the other” side of the ocean in today’s global market. This is especially true for homeopathic drugs\, the starting materials for many of which are available only from one continent or the other. \nHow do the regulations within the supplier’s country impact your ability to import those starting materials? What are the ramifications of the end marketer’s national requirements on the export of homeopathic starting materials? \nAttend this important and timely webinar to: \n\nReceive an overview of the regulatory frameworks for homeopathic drugs in the U.S. and E.U.;\nUnderstand the fundamental differences between the U.S. and E.U. regulatory requirements; and\nGain insights into what you need to know for importing and exporting homeopathic drugs between the U.S. and E.U.\n\nThis one-hour webinar will introduce your company to the myriad of aspects every company needs to consider in today’s international marketplace. Presented by two established experts in the field\, this webinar will provide companies with the framework to understand the differences and comparisons between the U.S. and E.U. regulatory requirements\, as well as the impact of “the other” on your company’s suppliers and markets. The webinar will also provide an awareness of the differences between the various national pharmacopeias and why an ignorance of “the other” can lead to your products being deemed as misbranded or adulterated. \n\n	\n\n\n	\n		\n	Presenters\nSteve Mann\, Director of External Global Regulatory Affairs & QPPV\, Nelsons\n\nSteve has worked with Nelsons for more than 15 years with 20 years experience in the field of global regulation for homoeopathic drugs\, cosmetics\, herbal and dietary supplements\, and medical devices. He has worked on and managed regulatory and compliance projects in North\, Central and South America\, Europe\, North and East Africa\, Asia\, and Australasia. \nSteve currently holds board positions with various industry trade bodies\, including the British Association of Homeopathic Manufacturers (BAHM)\, the European Coalition on Homeopathic and Anthroposophic Medicinal Products (ECHAMP)\, and the U.K. Health Food Manufacturers Association (HFMA). He is also a Member of the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) and sits on the Standards and Controls and Monograph Review Committees\, and the Council on Pharmacy. \nEric Foxman\, Consultant and Board Member\, HPCUS\nEric has a rich history of work in the homeopathic industry. He has been a member of the Homeopathic Pharmacopeia Convention of the United States since its founding in 1980 and is presently in his 12th year on the Board of Trustees. Eric serves as the Senior Scientist of the Convention and the Chair of the Council on Pharmacy. In these capacities\, Eric is very active in the on-going revision and updating of the contents of the HPUS. \nEric has been active a member or representative of the American Association of Homeopathic Pharmacists for over 38 years. He has presented numerous workshops on legal\, regulatory and technical aspects of the manufacturing and marketing of homeopathic drug products. He also presents updates to the HPUS through an annual webinar. Eric is a consultant to the homeopathic industry with a focus on helping companies achieve compliance with the myriad of regulatory requirements for companies’ high-quality\, well-formulated homeopathic drug products. \n\n	\n\n\n	\n		\n	Who Should Attend?\n\nAmerican companies purchasing homeopathic materials from Europe\nEuropean companies shipping homeopathic materials into the U.S.\nAmerican companies exporting or interested in exporting homeopathic products to Europe\nEuropean companies importing American homeopathic products\nCompliance managers\nPurchasing managers\nQuality managers\nThose responsible for import/export\n\n\n	\n\n\n	\n		\n	Cost\nNonmembers: $239\nAAHP Members: $149 (With $90 discount available from the AAHP office) \n  \n\n	\n\n\n	\n		\n	\n		Register Today!\n		\n	\n	\n		\n			\n							Click Here to Register
URL:https://theaahp.org/event/poison-control-in-2021/
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200723T140000
DTEND;TZID=America/New_York:20200723T150000
DTSTAMP:20260625T152947
CREATED:20200707T144243Z
LAST-MODIFIED:20210108T155835Z
UID:10000045-1595512800-1595516400@theaahp.org
SUMMARY:Homeopathic Shopper Panel in the Era of COVID-19
DESCRIPTION:11:00 a.m. ET • 10:00 a.m. CT • 9:00 a.m. MT • 8:00 a.m. PT • 16.00 GMT • 17.00 CET \n\n	\n\n\n\n	\n		\n	\n\n\n	\n						\n		\n\n			\n	\n	\n		\n	Summary\nWhether your company is located in the U.S. or the E.U.\, you need to be aware of regulations on “the other” side of the ocean in today’s global market. This is especially true for homeopathic drugs\, the starting materials for many of which are available only from one continent or the other. \nHow do the regulations within the supplier’s country impact your ability to import those starting materials? What are the ramifications of the end marketer’s national requirements on the export of homeopathic starting materials? \nAttend this important and timely webinar to: \n\nReceive an overview of the regulatory frameworks for homeopathic drugs in the U.S. and E.U.;\nUnderstand the fundamental differences between the U.S. and E.U. regulatory requirements; and\nGain insights into what you need to know for importing and exporting homeopathic drugs between the U.S. and E.U.\n\nThis one-hour webinar will introduce your company to the myriad of aspects every company needs to consider in today’s international marketplace. Presented by two established experts in the field\, this webinar will provide companies with the framework to understand the differences and comparisons between the U.S. and E.U. regulatory requirements\, as well as the impact of “the other” on your company’s suppliers and markets. The webinar will also provide an awareness of the differences between the various national pharmacopeias and why an ignorance of “the other” can lead to your products being deemed as misbranded or adulterated. \n\n	\n\n\n	\n		\n	Presenters\nSteve Mann\, Director of External Global Regulatory Affairs & QPPV\, Nelsons\n\nSteve has worked with Nelsons for more than 15 years with 20 years experience in the field of global regulation for homoeopathic drugs\, cosmetics\, herbal and dietary supplements\, and medical devices. He has worked on and managed regulatory and compliance projects in North\, Central and South America\, Europe\, North and East Africa\, Asia\, and Australasia. \nSteve currently holds board positions with various industry trade bodies\, including the British Association of Homeopathic Manufacturers (BAHM)\, the European Coalition on Homeopathic and Anthroposophic Medicinal Products (ECHAMP)\, and the U.K. Health Food Manufacturers Association (HFMA). He is also a Member of the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) and sits on the Standards and Controls and Monograph Review Committees\, and the Council on Pharmacy. \nEric Foxman\, Consultant and Board Member\, HPCUS\nEric has a rich history of work in the homeopathic industry. He has been a member of the Homeopathic Pharmacopeia Convention of the United States since its founding in 1980 and is presently in his 12th year on the Board of Trustees. Eric serves as the Senior Scientist of the Convention and the Chair of the Council on Pharmacy. In these capacities\, Eric is very active in the on-going revision and updating of the contents of the HPUS. \nEric has been active a member or representative of the American Association of Homeopathic Pharmacists for over 38 years. He has presented numerous workshops on legal\, regulatory and technical aspects of the manufacturing and marketing of homeopathic drug products. He also presents updates to the HPUS through an annual webinar. Eric is a consultant to the homeopathic industry with a focus on helping companies achieve compliance with the myriad of regulatory requirements for companies’ high-quality\, well-formulated homeopathic drug products. \n\n	\n\n\n	\n		\n	Who Should Attend?\n\nAmerican companies purchasing homeopathic materials from Europe\nEuropean companies shipping homeopathic materials into the U.S.\nAmerican companies exporting or interested in exporting homeopathic products to Europe\nEuropean companies importing American homeopathic products\nCompliance managers\nPurchasing managers\nQuality managers\nThose responsible for import/export\n\n\n	\n\n\n	\n		\n	Cost\nNonmembers: $239\nAAHP Members: $149 (With $90 discount available from the AAHP office) \n  \n\n	\n\n\n	\n		\n	\n		Register Today!\n		\n	\n	\n		\n			\n							Click Here to Register
URL:https://theaahp.org/event/shopper-panel/
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200618
DTEND;VALUE=DATE:20200619
DTSTAMP:20260625T152947
CREATED:20200601T132613Z
LAST-MODIFIED:20200601T132741Z
UID:10000064-1592438400-1592524799@theaahp.org
SUMMARY:2019–2020 HPUS Updates
DESCRIPTION:11:00 a.m. ET • 10:00 a.m. CT • 9:00 a.m. MT • 8:00 a.m. PT • 16.00 GMT • 17.00 CET \n\n	\n\n\n\n	\n		\n	\n\n\n	\n						\n		\n\n			\n	\n	\n		\n	Summary\nWhether your company is located in the U.S. or the E.U.\, you need to be aware of regulations on “the other” side of the ocean in today’s global market. This is especially true for homeopathic drugs\, the starting materials for many of which are available only from one continent or the other. \nHow do the regulations within the supplier’s country impact your ability to import those starting materials? What are the ramifications of the end marketer’s national requirements on the export of homeopathic starting materials? \nAttend this important and timely webinar to: \n\nReceive an overview of the regulatory frameworks for homeopathic drugs in the U.S. and E.U.;\nUnderstand the fundamental differences between the U.S. and E.U. regulatory requirements; and\nGain insights into what you need to know for importing and exporting homeopathic drugs between the U.S. and E.U.\n\nThis one-hour webinar will introduce your company to the myriad of aspects every company needs to consider in today’s international marketplace. Presented by two established experts in the field\, this webinar will provide companies with the framework to understand the differences and comparisons between the U.S. and E.U. regulatory requirements\, as well as the impact of “the other” on your company’s suppliers and markets. The webinar will also provide an awareness of the differences between the various national pharmacopeias and why an ignorance of “the other” can lead to your products being deemed as misbranded or adulterated. \n\n	\n\n\n	\n		\n	Presenters\nSteve Mann\, Director of External Global Regulatory Affairs & QPPV\, Nelsons\n\nSteve has worked with Nelsons for more than 15 years with 20 years experience in the field of global regulation for homoeopathic drugs\, cosmetics\, herbal and dietary supplements\, and medical devices. He has worked on and managed regulatory and compliance projects in North\, Central and South America\, Europe\, North and East Africa\, Asia\, and Australasia. \nSteve currently holds board positions with various industry trade bodies\, including the British Association of Homeopathic Manufacturers (BAHM)\, the European Coalition on Homeopathic and Anthroposophic Medicinal Products (ECHAMP)\, and the U.K. Health Food Manufacturers Association (HFMA). He is also a Member of the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) and sits on the Standards and Controls and Monograph Review Committees\, and the Council on Pharmacy. \nEric Foxman\, Consultant and Board Member\, HPCUS\nEric has a rich history of work in the homeopathic industry. He has been a member of the Homeopathic Pharmacopeia Convention of the United States since its founding in 1980 and is presently in his 12th year on the Board of Trustees. Eric serves as the Senior Scientist of the Convention and the Chair of the Council on Pharmacy. In these capacities\, Eric is very active in the on-going revision and updating of the contents of the HPUS. \nEric has been active a member or representative of the American Association of Homeopathic Pharmacists for over 38 years. He has presented numerous workshops on legal\, regulatory and technical aspects of the manufacturing and marketing of homeopathic drug products. He also presents updates to the HPUS through an annual webinar. Eric is a consultant to the homeopathic industry with a focus on helping companies achieve compliance with the myriad of regulatory requirements for companies’ high-quality\, well-formulated homeopathic drug products. \n\n	\n\n\n	\n		\n	Who Should Attend?\n\nAmerican companies purchasing homeopathic materials from Europe\nEuropean companies shipping homeopathic materials into the U.S.\nAmerican companies exporting or interested in exporting homeopathic products to Europe\nEuropean companies importing American homeopathic products\nCompliance managers\nPurchasing managers\nQuality managers\nThose responsible for import/export\n\n\n	\n\n\n	\n		\n	Cost\nNonmembers: $239\nAAHP Members: $149 (With $90 discount available from the AAHP office) \n  \n\n	\n\n\n	\n		\n	\n		Register Today!\n		\n	\n	\n		\n			\n							Click Here to Register
URL:https://theaahp.org/event/hpus-updates/
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190515T130000
DTEND;TZID=America/New_York:20190515T140000
DTSTAMP:20260625T152947
CREATED:20190402T225547Z
LAST-MODIFIED:20190408T203512Z
UID:10000072-1557925200-1557928800@theaahp.org
SUMMARY:Live Webinar: 2018/2019 HPUS Updates
DESCRIPTION:11:00 a.m. ET • 10:00 a.m. CT • 9:00 a.m. MT • 8:00 a.m. PT • 16.00 GMT • 17.00 CET \n\n	\n\n\n\n	\n		\n	\n\n\n	\n						\n		\n\n			\n	\n	\n		\n	Summary\nWhether your company is located in the U.S. or the E.U.\, you need to be aware of regulations on “the other” side of the ocean in today’s global market. This is especially true for homeopathic drugs\, the starting materials for many of which are available only from one continent or the other. \nHow do the regulations within the supplier’s country impact your ability to import those starting materials? What are the ramifications of the end marketer’s national requirements on the export of homeopathic starting materials? \nAttend this important and timely webinar to: \n\nReceive an overview of the regulatory frameworks for homeopathic drugs in the U.S. and E.U.;\nUnderstand the fundamental differences between the U.S. and E.U. regulatory requirements; and\nGain insights into what you need to know for importing and exporting homeopathic drugs between the U.S. and E.U.\n\nThis one-hour webinar will introduce your company to the myriad of aspects every company needs to consider in today’s international marketplace. Presented by two established experts in the field\, this webinar will provide companies with the framework to understand the differences and comparisons between the U.S. and E.U. regulatory requirements\, as well as the impact of “the other” on your company’s suppliers and markets. The webinar will also provide an awareness of the differences between the various national pharmacopeias and why an ignorance of “the other” can lead to your products being deemed as misbranded or adulterated. \n\n	\n\n\n	\n		\n	Presenters\nSteve Mann\, Director of External Global Regulatory Affairs & QPPV\, Nelsons\n\nSteve has worked with Nelsons for more than 15 years with 20 years experience in the field of global regulation for homoeopathic drugs\, cosmetics\, herbal and dietary supplements\, and medical devices. He has worked on and managed regulatory and compliance projects in North\, Central and South America\, Europe\, North and East Africa\, Asia\, and Australasia. \nSteve currently holds board positions with various industry trade bodies\, including the British Association of Homeopathic Manufacturers (BAHM)\, the European Coalition on Homeopathic and Anthroposophic Medicinal Products (ECHAMP)\, and the U.K. Health Food Manufacturers Association (HFMA). He is also a Member of the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) and sits on the Standards and Controls and Monograph Review Committees\, and the Council on Pharmacy. \nEric Foxman\, Consultant and Board Member\, HPCUS\nEric has a rich history of work in the homeopathic industry. He has been a member of the Homeopathic Pharmacopeia Convention of the United States since its founding in 1980 and is presently in his 12th year on the Board of Trustees. Eric serves as the Senior Scientist of the Convention and the Chair of the Council on Pharmacy. In these capacities\, Eric is very active in the on-going revision and updating of the contents of the HPUS. \nEric has been active a member or representative of the American Association of Homeopathic Pharmacists for over 38 years. He has presented numerous workshops on legal\, regulatory and technical aspects of the manufacturing and marketing of homeopathic drug products. He also presents updates to the HPUS through an annual webinar. Eric is a consultant to the homeopathic industry with a focus on helping companies achieve compliance with the myriad of regulatory requirements for companies’ high-quality\, well-formulated homeopathic drug products. \n\n	\n\n\n	\n		\n	Who Should Attend?\n\nAmerican companies purchasing homeopathic materials from Europe\nEuropean companies shipping homeopathic materials into the U.S.\nAmerican companies exporting or interested in exporting homeopathic products to Europe\nEuropean companies importing American homeopathic products\nCompliance managers\nPurchasing managers\nQuality managers\nThose responsible for import/export\n\n\n	\n\n\n	\n		\n	Cost\nNonmembers: $239\nAAHP Members: $149 (With $90 discount available from the AAHP office) \n  \n\n	\n\n\n	\n		\n	\n		Register Today!\n		\n	\n	\n		\n			\n							Click Here to Register
URL:https://theaahp.org/event/live-webinar-2018-2019-hpus-updates/
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190110T110000
DTEND;TZID=America/New_York:20190110T120000
DTSTAMP:20260625T152947
CREATED:20181130T202133Z
LAST-MODIFIED:20181219T203157Z
UID:10000069-1547118000-1547121600@theaahp.org
SUMMARY:Live Webinar: U.S. & E.U. Regulations  - The Impact of "the Other" on Your Homeopathic Business
DESCRIPTION:11:00 a.m. ET • 10:00 a.m. CT • 9:00 a.m. MT • 8:00 a.m. PT • 16.00 GMT • 17.00 CET \n\n	\n\n\n\n	\n		\n	\n\n\n	\n						\n		\n\n			\n	\n	\n		\n	Summary\nWhether your company is located in the U.S. or the E.U.\, you need to be aware of regulations on “the other” side of the ocean in today’s global market. This is especially true for homeopathic drugs\, the starting materials for many of which are available only from one continent or the other. \nHow do the regulations within the supplier’s country impact your ability to import those starting materials? What are the ramifications of the end marketer’s national requirements on the export of homeopathic starting materials? \nAttend this important and timely webinar to: \n\nReceive an overview of the regulatory frameworks for homeopathic drugs in the U.S. and E.U.;\nUnderstand the fundamental differences between the U.S. and E.U. regulatory requirements; and\nGain insights into what you need to know for importing and exporting homeopathic drugs between the U.S. and E.U.\n\nThis one-hour webinar will introduce your company to the myriad of aspects every company needs to consider in today’s international marketplace. Presented by two established experts in the field\, this webinar will provide companies with the framework to understand the differences and comparisons between the U.S. and E.U. regulatory requirements\, as well as the impact of “the other” on your company’s suppliers and markets. The webinar will also provide an awareness of the differences between the various national pharmacopeias and why an ignorance of “the other” can lead to your products being deemed as misbranded or adulterated. \n\n	\n\n\n	\n		\n	Presenters\nSteve Mann\, Director of External Global Regulatory Affairs & QPPV\, Nelsons\n\nSteve has worked with Nelsons for more than 15 years with 20 years experience in the field of global regulation for homoeopathic drugs\, cosmetics\, herbal and dietary supplements\, and medical devices. He has worked on and managed regulatory and compliance projects in North\, Central and South America\, Europe\, North and East Africa\, Asia\, and Australasia. \nSteve currently holds board positions with various industry trade bodies\, including the British Association of Homeopathic Manufacturers (BAHM)\, the European Coalition on Homeopathic and Anthroposophic Medicinal Products (ECHAMP)\, and the U.K. Health Food Manufacturers Association (HFMA). He is also a Member of the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) and sits on the Standards and Controls and Monograph Review Committees\, and the Council on Pharmacy. \nEric Foxman\, Consultant and Board Member\, HPCUS\nEric has a rich history of work in the homeopathic industry. He has been a member of the Homeopathic Pharmacopeia Convention of the United States since its founding in 1980 and is presently in his 12th year on the Board of Trustees. Eric serves as the Senior Scientist of the Convention and the Chair of the Council on Pharmacy. In these capacities\, Eric is very active in the on-going revision and updating of the contents of the HPUS. \nEric has been active a member or representative of the American Association of Homeopathic Pharmacists for over 38 years. He has presented numerous workshops on legal\, regulatory and technical aspects of the manufacturing and marketing of homeopathic drug products. He also presents updates to the HPUS through an annual webinar. Eric is a consultant to the homeopathic industry with a focus on helping companies achieve compliance with the myriad of regulatory requirements for companies’ high-quality\, well-formulated homeopathic drug products. \n\n	\n\n\n	\n		\n	Who Should Attend?\n\nAmerican companies purchasing homeopathic materials from Europe\nEuropean companies shipping homeopathic materials into the U.S.\nAmerican companies exporting or interested in exporting homeopathic products to Europe\nEuropean companies importing American homeopathic products\nCompliance managers\nPurchasing managers\nQuality managers\nThose responsible for import/export\n\n\n	\n\n\n	\n		\n	Cost\nNonmembers: $239\nAAHP Members: $149 (With $90 discount available from the AAHP office) \n  \n\n	\n\n\n	\n		\n	\n		Register Today!\n		\n	\n	\n		\n			\n							Click Here to Register
URL:https://theaahp.org/event/live-webinar-u-s-e-u-regulations-the-impact-of-the-other-on-your-homeopathic-business/
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180516T130000
DTEND;TZID=America/New_York:20180516T140000
DTSTAMP:20260625T152947
CREATED:20180424T151916Z
LAST-MODIFIED:20180424T151916Z
UID:10000068-1526475600-1526479200@theaahp.org
SUMMARY:Live Webinar: HPUS Updates 2017/2018
DESCRIPTION:11:00 a.m. ET • 10:00 a.m. CT • 9:00 a.m. MT • 8:00 a.m. PT • 16.00 GMT • 17.00 CET \n\n	\n\n\n\n	\n		\n	\n\n\n	\n						\n		\n\n			\n	\n	\n		\n	Summary\nWhether your company is located in the U.S. or the E.U.\, you need to be aware of regulations on “the other” side of the ocean in today’s global market. This is especially true for homeopathic drugs\, the starting materials for many of which are available only from one continent or the other. \nHow do the regulations within the supplier’s country impact your ability to import those starting materials? What are the ramifications of the end marketer’s national requirements on the export of homeopathic starting materials? \nAttend this important and timely webinar to: \n\nReceive an overview of the regulatory frameworks for homeopathic drugs in the U.S. and E.U.;\nUnderstand the fundamental differences between the U.S. and E.U. regulatory requirements; and\nGain insights into what you need to know for importing and exporting homeopathic drugs between the U.S. and E.U.\n\nThis one-hour webinar will introduce your company to the myriad of aspects every company needs to consider in today’s international marketplace. Presented by two established experts in the field\, this webinar will provide companies with the framework to understand the differences and comparisons between the U.S. and E.U. regulatory requirements\, as well as the impact of “the other” on your company’s suppliers and markets. The webinar will also provide an awareness of the differences between the various national pharmacopeias and why an ignorance of “the other” can lead to your products being deemed as misbranded or adulterated. \n\n	\n\n\n	\n		\n	Presenters\nSteve Mann\, Director of External Global Regulatory Affairs & QPPV\, Nelsons\n\nSteve has worked with Nelsons for more than 15 years with 20 years experience in the field of global regulation for homoeopathic drugs\, cosmetics\, herbal and dietary supplements\, and medical devices. He has worked on and managed regulatory and compliance projects in North\, Central and South America\, Europe\, North and East Africa\, Asia\, and Australasia. \nSteve currently holds board positions with various industry trade bodies\, including the British Association of Homeopathic Manufacturers (BAHM)\, the European Coalition on Homeopathic and Anthroposophic Medicinal Products (ECHAMP)\, and the U.K. Health Food Manufacturers Association (HFMA). He is also a Member of the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) and sits on the Standards and Controls and Monograph Review Committees\, and the Council on Pharmacy. \nEric Foxman\, Consultant and Board Member\, HPCUS\nEric has a rich history of work in the homeopathic industry. He has been a member of the Homeopathic Pharmacopeia Convention of the United States since its founding in 1980 and is presently in his 12th year on the Board of Trustees. Eric serves as the Senior Scientist of the Convention and the Chair of the Council on Pharmacy. In these capacities\, Eric is very active in the on-going revision and updating of the contents of the HPUS. \nEric has been active a member or representative of the American Association of Homeopathic Pharmacists for over 38 years. He has presented numerous workshops on legal\, regulatory and technical aspects of the manufacturing and marketing of homeopathic drug products. He also presents updates to the HPUS through an annual webinar. Eric is a consultant to the homeopathic industry with a focus on helping companies achieve compliance with the myriad of regulatory requirements for companies’ high-quality\, well-formulated homeopathic drug products. \n\n	\n\n\n	\n		\n	Who Should Attend?\n\nAmerican companies purchasing homeopathic materials from Europe\nEuropean companies shipping homeopathic materials into the U.S.\nAmerican companies exporting or interested in exporting homeopathic products to Europe\nEuropean companies importing American homeopathic products\nCompliance managers\nPurchasing managers\nQuality managers\nThose responsible for import/export\n\n\n	\n\n\n	\n		\n	Cost\nNonmembers: $239\nAAHP Members: $149 (With $90 discount available from the AAHP office) \n  \n\n	\n\n\n	\n		\n	\n		Register Today!\n		\n	\n	\n		\n			\n							Click Here to Register
URL:https://theaahp.org/event/live-webinar-hpus-updates-2017-2018/
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20170518T130000
DTEND;TZID=America/New_York:20170518T140000
DTSTAMP:20260625T152947
CREATED:20170426T171219Z
LAST-MODIFIED:20170511T180610Z
UID:10000048-1495112400-1495116000@theaahp.org
SUMMARY:2017 HPUS Updates: A Webinar on Homeopathic GMPs and Stability
DESCRIPTION:11:00 a.m. ET • 10:00 a.m. CT • 9:00 a.m. MT • 8:00 a.m. PT • 16.00 GMT • 17.00 CET \n\n	\n\n\n\n	\n		\n	\n\n\n	\n						\n		\n\n			\n	\n	\n		\n	Summary\nWhether your company is located in the U.S. or the E.U.\, you need to be aware of regulations on “the other” side of the ocean in today’s global market. This is especially true for homeopathic drugs\, the starting materials for many of which are available only from one continent or the other. \nHow do the regulations within the supplier’s country impact your ability to import those starting materials? What are the ramifications of the end marketer’s national requirements on the export of homeopathic starting materials? \nAttend this important and timely webinar to: \n\nReceive an overview of the regulatory frameworks for homeopathic drugs in the U.S. and E.U.;\nUnderstand the fundamental differences between the U.S. and E.U. regulatory requirements; and\nGain insights into what you need to know for importing and exporting homeopathic drugs between the U.S. and E.U.\n\nThis one-hour webinar will introduce your company to the myriad of aspects every company needs to consider in today’s international marketplace. Presented by two established experts in the field\, this webinar will provide companies with the framework to understand the differences and comparisons between the U.S. and E.U. regulatory requirements\, as well as the impact of “the other” on your company’s suppliers and markets. The webinar will also provide an awareness of the differences between the various national pharmacopeias and why an ignorance of “the other” can lead to your products being deemed as misbranded or adulterated. \n\n	\n\n\n	\n		\n	Presenters\nSteve Mann\, Director of External Global Regulatory Affairs & QPPV\, Nelsons\n\nSteve has worked with Nelsons for more than 15 years with 20 years experience in the field of global regulation for homoeopathic drugs\, cosmetics\, herbal and dietary supplements\, and medical devices. He has worked on and managed regulatory and compliance projects in North\, Central and South America\, Europe\, North and East Africa\, Asia\, and Australasia. \nSteve currently holds board positions with various industry trade bodies\, including the British Association of Homeopathic Manufacturers (BAHM)\, the European Coalition on Homeopathic and Anthroposophic Medicinal Products (ECHAMP)\, and the U.K. Health Food Manufacturers Association (HFMA). He is also a Member of the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) and sits on the Standards and Controls and Monograph Review Committees\, and the Council on Pharmacy. \nEric Foxman\, Consultant and Board Member\, HPCUS\nEric has a rich history of work in the homeopathic industry. He has been a member of the Homeopathic Pharmacopeia Convention of the United States since its founding in 1980 and is presently in his 12th year on the Board of Trustees. Eric serves as the Senior Scientist of the Convention and the Chair of the Council on Pharmacy. In these capacities\, Eric is very active in the on-going revision and updating of the contents of the HPUS. \nEric has been active a member or representative of the American Association of Homeopathic Pharmacists for over 38 years. He has presented numerous workshops on legal\, regulatory and technical aspects of the manufacturing and marketing of homeopathic drug products. He also presents updates to the HPUS through an annual webinar. Eric is a consultant to the homeopathic industry with a focus on helping companies achieve compliance with the myriad of regulatory requirements for companies’ high-quality\, well-formulated homeopathic drug products. \n\n	\n\n\n	\n		\n	Who Should Attend?\n\nAmerican companies purchasing homeopathic materials from Europe\nEuropean companies shipping homeopathic materials into the U.S.\nAmerican companies exporting or interested in exporting homeopathic products to Europe\nEuropean companies importing American homeopathic products\nCompliance managers\nPurchasing managers\nQuality managers\nThose responsible for import/export\n\n\n	\n\n\n	\n		\n	Cost\nNonmembers: $239\nAAHP Members: $149 (With $90 discount available from the AAHP office) \n  \n\n	\n\n\n	\n		\n	\n		Register Today!\n		\n	\n	\n		\n			\n							Click Here to Register
URL:https://theaahp.org/event/2017-hpus-updates-a-webinar-on-homeopathic-gmps-and-stability/
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20150111
DTEND;VALUE=DATE:20180111
DTSTAMP:20260625T152947
CREATED:20140127T202949Z
LAST-MODIFIED:20150123T183958Z
UID:10000056-1420934400-1515628799@theaahp.org
SUMMARY:Best Branding Practices Webinar Archive
DESCRIPTION:11:00 a.m. ET • 10:00 a.m. CT • 9:00 a.m. MT • 8:00 a.m. PT • 16.00 GMT • 17.00 CET \n\n	\n\n\n\n	\n		\n	\n\n\n	\n						\n		\n\n			\n	\n	\n		\n	Summary\nWhether your company is located in the U.S. or the E.U.\, you need to be aware of regulations on “the other” side of the ocean in today’s global market. This is especially true for homeopathic drugs\, the starting materials for many of which are available only from one continent or the other. \nHow do the regulations within the supplier’s country impact your ability to import those starting materials? What are the ramifications of the end marketer’s national requirements on the export of homeopathic starting materials? \nAttend this important and timely webinar to: \n\nReceive an overview of the regulatory frameworks for homeopathic drugs in the U.S. and E.U.;\nUnderstand the fundamental differences between the U.S. and E.U. regulatory requirements; and\nGain insights into what you need to know for importing and exporting homeopathic drugs between the U.S. and E.U.\n\nThis one-hour webinar will introduce your company to the myriad of aspects every company needs to consider in today’s international marketplace. Presented by two established experts in the field\, this webinar will provide companies with the framework to understand the differences and comparisons between the U.S. and E.U. regulatory requirements\, as well as the impact of “the other” on your company’s suppliers and markets. The webinar will also provide an awareness of the differences between the various national pharmacopeias and why an ignorance of “the other” can lead to your products being deemed as misbranded or adulterated. \n\n	\n\n\n	\n		\n	Presenters\nSteve Mann\, Director of External Global Regulatory Affairs & QPPV\, Nelsons\n\nSteve has worked with Nelsons for more than 15 years with 20 years experience in the field of global regulation for homoeopathic drugs\, cosmetics\, herbal and dietary supplements\, and medical devices. He has worked on and managed regulatory and compliance projects in North\, Central and South America\, Europe\, North and East Africa\, Asia\, and Australasia. \nSteve currently holds board positions with various industry trade bodies\, including the British Association of Homeopathic Manufacturers (BAHM)\, the European Coalition on Homeopathic and Anthroposophic Medicinal Products (ECHAMP)\, and the U.K. Health Food Manufacturers Association (HFMA). He is also a Member of the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) and sits on the Standards and Controls and Monograph Review Committees\, and the Council on Pharmacy. \nEric Foxman\, Consultant and Board Member\, HPCUS\nEric has a rich history of work in the homeopathic industry. He has been a member of the Homeopathic Pharmacopeia Convention of the United States since its founding in 1980 and is presently in his 12th year on the Board of Trustees. Eric serves as the Senior Scientist of the Convention and the Chair of the Council on Pharmacy. In these capacities\, Eric is very active in the on-going revision and updating of the contents of the HPUS. \nEric has been active a member or representative of the American Association of Homeopathic Pharmacists for over 38 years. He has presented numerous workshops on legal\, regulatory and technical aspects of the manufacturing and marketing of homeopathic drug products. He also presents updates to the HPUS through an annual webinar. Eric is a consultant to the homeopathic industry with a focus on helping companies achieve compliance with the myriad of regulatory requirements for companies’ high-quality\, well-formulated homeopathic drug products. \n\n	\n\n\n	\n		\n	Who Should Attend?\n\nAmerican companies purchasing homeopathic materials from Europe\nEuropean companies shipping homeopathic materials into the U.S.\nAmerican companies exporting or interested in exporting homeopathic products to Europe\nEuropean companies importing American homeopathic products\nCompliance managers\nPurchasing managers\nQuality managers\nThose responsible for import/export\n\n\n	\n\n\n	\n		\n	Cost\nNonmembers: $239\nAAHP Members: $149 (With $90 discount available from the AAHP office) \n  \n\n	\n\n\n	\n		\n	\n		Register Today!\n		\n	\n	\n		\n			\n							Click Here to Register
URL:https://theaahp.org/event/best-branding-practices/
LOCATION:Webinar Archive
CATEGORIES:Webinar,Webinar Archive
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20150110
DTEND;VALUE=DATE:20180110
DTSTAMP:20260625T152947
CREATED:20140127T203742Z
LAST-MODIFIED:20150123T183039Z
UID:10000054-1420848000-1515542399@theaahp.org
SUMMARY:Managing Consumer Calls: Complaints\, cGMP Compliance\, Quality and Service Webinar Archive
DESCRIPTION:11:00 a.m. ET • 10:00 a.m. CT • 9:00 a.m. MT • 8:00 a.m. PT • 16.00 GMT • 17.00 CET \n\n	\n\n\n\n	\n		\n	\n\n\n	\n						\n		\n\n			\n	\n	\n		\n	Summary\nWhether your company is located in the U.S. or the E.U.\, you need to be aware of regulations on “the other” side of the ocean in today’s global market. This is especially true for homeopathic drugs\, the starting materials for many of which are available only from one continent or the other. \nHow do the regulations within the supplier’s country impact your ability to import those starting materials? What are the ramifications of the end marketer’s national requirements on the export of homeopathic starting materials? \nAttend this important and timely webinar to: \n\nReceive an overview of the regulatory frameworks for homeopathic drugs in the U.S. and E.U.;\nUnderstand the fundamental differences between the U.S. and E.U. regulatory requirements; and\nGain insights into what you need to know for importing and exporting homeopathic drugs between the U.S. and E.U.\n\nThis one-hour webinar will introduce your company to the myriad of aspects every company needs to consider in today’s international marketplace. Presented by two established experts in the field\, this webinar will provide companies with the framework to understand the differences and comparisons between the U.S. and E.U. regulatory requirements\, as well as the impact of “the other” on your company’s suppliers and markets. The webinar will also provide an awareness of the differences between the various national pharmacopeias and why an ignorance of “the other” can lead to your products being deemed as misbranded or adulterated. \n\n	\n\n\n	\n		\n	Presenters\nSteve Mann\, Director of External Global Regulatory Affairs & QPPV\, Nelsons\n\nSteve has worked with Nelsons for more than 15 years with 20 years experience in the field of global regulation for homoeopathic drugs\, cosmetics\, herbal and dietary supplements\, and medical devices. He has worked on and managed regulatory and compliance projects in North\, Central and South America\, Europe\, North and East Africa\, Asia\, and Australasia. \nSteve currently holds board positions with various industry trade bodies\, including the British Association of Homeopathic Manufacturers (BAHM)\, the European Coalition on Homeopathic and Anthroposophic Medicinal Products (ECHAMP)\, and the U.K. Health Food Manufacturers Association (HFMA). He is also a Member of the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) and sits on the Standards and Controls and Monograph Review Committees\, and the Council on Pharmacy. \nEric Foxman\, Consultant and Board Member\, HPCUS\nEric has a rich history of work in the homeopathic industry. He has been a member of the Homeopathic Pharmacopeia Convention of the United States since its founding in 1980 and is presently in his 12th year on the Board of Trustees. Eric serves as the Senior Scientist of the Convention and the Chair of the Council on Pharmacy. In these capacities\, Eric is very active in the on-going revision and updating of the contents of the HPUS. \nEric has been active a member or representative of the American Association of Homeopathic Pharmacists for over 38 years. He has presented numerous workshops on legal\, regulatory and technical aspects of the manufacturing and marketing of homeopathic drug products. He also presents updates to the HPUS through an annual webinar. Eric is a consultant to the homeopathic industry with a focus on helping companies achieve compliance with the myriad of regulatory requirements for companies’ high-quality\, well-formulated homeopathic drug products. \n\n	\n\n\n	\n		\n	Who Should Attend?\n\nAmerican companies purchasing homeopathic materials from Europe\nEuropean companies shipping homeopathic materials into the U.S.\nAmerican companies exporting or interested in exporting homeopathic products to Europe\nEuropean companies importing American homeopathic products\nCompliance managers\nPurchasing managers\nQuality managers\nThose responsible for import/export\n\n\n	\n\n\n	\n		\n	Cost\nNonmembers: $239\nAAHP Members: $149 (With $90 discount available from the AAHP office) \n  \n\n	\n\n\n	\n		\n	\n		Register Today!\n		\n	\n	\n		\n			\n							Click Here to Register
URL:https://theaahp.org/event/managing-consumer-calls-complaints-cgmp-compliance-quality-and-service/
LOCATION:Webinar Archive
CATEGORIES:Webinar,Webinar Archive
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20150109
DTEND;VALUE=DATE:20180109
DTSTAMP:20260625T152947
CREATED:20140127T204309Z
LAST-MODIFIED:20150123T183007Z
UID:10000053-1420761600-1515455999@theaahp.org
SUMMARY:From Leaf to Label - Quality Throughout the Cycle -- Webinar Archive
DESCRIPTION:11:00 a.m. ET • 10:00 a.m. CT • 9:00 a.m. MT • 8:00 a.m. PT • 16.00 GMT • 17.00 CET \n\n	\n\n\n\n	\n		\n	\n\n\n	\n						\n		\n\n			\n	\n	\n		\n	Summary\nWhether your company is located in the U.S. or the E.U.\, you need to be aware of regulations on “the other” side of the ocean in today’s global market. This is especially true for homeopathic drugs\, the starting materials for many of which are available only from one continent or the other. \nHow do the regulations within the supplier’s country impact your ability to import those starting materials? What are the ramifications of the end marketer’s national requirements on the export of homeopathic starting materials? \nAttend this important and timely webinar to: \n\nReceive an overview of the regulatory frameworks for homeopathic drugs in the U.S. and E.U.;\nUnderstand the fundamental differences between the U.S. and E.U. regulatory requirements; and\nGain insights into what you need to know for importing and exporting homeopathic drugs between the U.S. and E.U.\n\nThis one-hour webinar will introduce your company to the myriad of aspects every company needs to consider in today’s international marketplace. Presented by two established experts in the field\, this webinar will provide companies with the framework to understand the differences and comparisons between the U.S. and E.U. regulatory requirements\, as well as the impact of “the other” on your company’s suppliers and markets. The webinar will also provide an awareness of the differences between the various national pharmacopeias and why an ignorance of “the other” can lead to your products being deemed as misbranded or adulterated. \n\n	\n\n\n	\n		\n	Presenters\nSteve Mann\, Director of External Global Regulatory Affairs & QPPV\, Nelsons\n\nSteve has worked with Nelsons for more than 15 years with 20 years experience in the field of global regulation for homoeopathic drugs\, cosmetics\, herbal and dietary supplements\, and medical devices. He has worked on and managed regulatory and compliance projects in North\, Central and South America\, Europe\, North and East Africa\, Asia\, and Australasia. \nSteve currently holds board positions with various industry trade bodies\, including the British Association of Homeopathic Manufacturers (BAHM)\, the European Coalition on Homeopathic and Anthroposophic Medicinal Products (ECHAMP)\, and the U.K. Health Food Manufacturers Association (HFMA). He is also a Member of the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) and sits on the Standards and Controls and Monograph Review Committees\, and the Council on Pharmacy. \nEric Foxman\, Consultant and Board Member\, HPCUS\nEric has a rich history of work in the homeopathic industry. He has been a member of the Homeopathic Pharmacopeia Convention of the United States since its founding in 1980 and is presently in his 12th year on the Board of Trustees. Eric serves as the Senior Scientist of the Convention and the Chair of the Council on Pharmacy. In these capacities\, Eric is very active in the on-going revision and updating of the contents of the HPUS. \nEric has been active a member or representative of the American Association of Homeopathic Pharmacists for over 38 years. He has presented numerous workshops on legal\, regulatory and technical aspects of the manufacturing and marketing of homeopathic drug products. He also presents updates to the HPUS through an annual webinar. Eric is a consultant to the homeopathic industry with a focus on helping companies achieve compliance with the myriad of regulatory requirements for companies’ high-quality\, well-formulated homeopathic drug products. \n\n	\n\n\n	\n		\n	Who Should Attend?\n\nAmerican companies purchasing homeopathic materials from Europe\nEuropean companies shipping homeopathic materials into the U.S.\nAmerican companies exporting or interested in exporting homeopathic products to Europe\nEuropean companies importing American homeopathic products\nCompliance managers\nPurchasing managers\nQuality managers\nThose responsible for import/export\n\n\n	\n\n\n	\n		\n	Cost\nNonmembers: $239\nAAHP Members: $149 (With $90 discount available from the AAHP office) \n  \n\n	\n\n\n	\n		\n	\n		Register Today!\n		\n	\n	\n		\n			\n							Click Here to Register
URL:https://theaahp.org/event/from-leaf-to-label/
LOCATION:Webinar Archive
CATEGORIES:Webinar,Webinar Archive
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20150108
DTEND;VALUE=DATE:20180108
DTSTAMP:20260625T152947
CREATED:20140127T203405Z
LAST-MODIFIED:20150123T182934Z
UID:10000055-1420675200-1515369599@theaahp.org
SUMMARY:Managing Contract Manufacturing Responsibilities and Relationships Webinar Archive
DESCRIPTION:11:00 a.m. ET • 10:00 a.m. CT • 9:00 a.m. MT • 8:00 a.m. PT • 16.00 GMT • 17.00 CET \n\n	\n\n\n\n	\n		\n	\n\n\n	\n						\n		\n\n			\n	\n	\n		\n	Summary\nWhether your company is located in the U.S. or the E.U.\, you need to be aware of regulations on “the other” side of the ocean in today’s global market. This is especially true for homeopathic drugs\, the starting materials for many of which are available only from one continent or the other. \nHow do the regulations within the supplier’s country impact your ability to import those starting materials? What are the ramifications of the end marketer’s national requirements on the export of homeopathic starting materials? \nAttend this important and timely webinar to: \n\nReceive an overview of the regulatory frameworks for homeopathic drugs in the U.S. and E.U.;\nUnderstand the fundamental differences between the U.S. and E.U. regulatory requirements; and\nGain insights into what you need to know for importing and exporting homeopathic drugs between the U.S. and E.U.\n\nThis one-hour webinar will introduce your company to the myriad of aspects every company needs to consider in today’s international marketplace. Presented by two established experts in the field\, this webinar will provide companies with the framework to understand the differences and comparisons between the U.S. and E.U. regulatory requirements\, as well as the impact of “the other” on your company’s suppliers and markets. The webinar will also provide an awareness of the differences between the various national pharmacopeias and why an ignorance of “the other” can lead to your products being deemed as misbranded or adulterated. \n\n	\n\n\n	\n		\n	Presenters\nSteve Mann\, Director of External Global Regulatory Affairs & QPPV\, Nelsons\n\nSteve has worked with Nelsons for more than 15 years with 20 years experience in the field of global regulation for homoeopathic drugs\, cosmetics\, herbal and dietary supplements\, and medical devices. He has worked on and managed regulatory and compliance projects in North\, Central and South America\, Europe\, North and East Africa\, Asia\, and Australasia. \nSteve currently holds board positions with various industry trade bodies\, including the British Association of Homeopathic Manufacturers (BAHM)\, the European Coalition on Homeopathic and Anthroposophic Medicinal Products (ECHAMP)\, and the U.K. Health Food Manufacturers Association (HFMA). He is also a Member of the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) and sits on the Standards and Controls and Monograph Review Committees\, and the Council on Pharmacy. \nEric Foxman\, Consultant and Board Member\, HPCUS\nEric has a rich history of work in the homeopathic industry. He has been a member of the Homeopathic Pharmacopeia Convention of the United States since its founding in 1980 and is presently in his 12th year on the Board of Trustees. Eric serves as the Senior Scientist of the Convention and the Chair of the Council on Pharmacy. In these capacities\, Eric is very active in the on-going revision and updating of the contents of the HPUS. \nEric has been active a member or representative of the American Association of Homeopathic Pharmacists for over 38 years. He has presented numerous workshops on legal\, regulatory and technical aspects of the manufacturing and marketing of homeopathic drug products. He also presents updates to the HPUS through an annual webinar. Eric is a consultant to the homeopathic industry with a focus on helping companies achieve compliance with the myriad of regulatory requirements for companies’ high-quality\, well-formulated homeopathic drug products. \n\n	\n\n\n	\n		\n	Who Should Attend?\n\nAmerican companies purchasing homeopathic materials from Europe\nEuropean companies shipping homeopathic materials into the U.S.\nAmerican companies exporting or interested in exporting homeopathic products to Europe\nEuropean companies importing American homeopathic products\nCompliance managers\nPurchasing managers\nQuality managers\nThose responsible for import/export\n\n\n	\n\n\n	\n		\n	Cost\nNonmembers: $239\nAAHP Members: $149 (With $90 discount available from the AAHP office) \n  \n\n	\n\n\n	\n		\n	\n		Register Today!\n		\n	\n	\n		\n			\n							Click Here to Register
URL:https://theaahp.org/event/managing-contract-manufacturing-responsibilities-and-relationships/
LOCATION:Webinar Archive
CATEGORIES:Webinar,Webinar Archive
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20150107
DTEND;VALUE=DATE:20180108
DTSTAMP:20260625T152947
CREATED:20150123T181933Z
LAST-MODIFIED:20230321T192241Z
UID:10000050-1420588800-1515369599@theaahp.org
SUMMARY:The Homeopathic Market – Analytical Tools for Understanding and Growth  Webinar Archive
DESCRIPTION:11:00 a.m. ET • 10:00 a.m. CT • 9:00 a.m. MT • 8:00 a.m. PT • 16.00 GMT • 17.00 CET \n\n	\n\n\n\n	\n		\n	\n\n\n	\n						\n		\n\n			\n	\n	\n		\n	Summary\nWhether your company is located in the U.S. or the E.U.\, you need to be aware of regulations on “the other” side of the ocean in today’s global market. This is especially true for homeopathic drugs\, the starting materials for many of which are available only from one continent or the other. \nHow do the regulations within the supplier’s country impact your ability to import those starting materials? What are the ramifications of the end marketer’s national requirements on the export of homeopathic starting materials? \nAttend this important and timely webinar to: \n\nReceive an overview of the regulatory frameworks for homeopathic drugs in the U.S. and E.U.;\nUnderstand the fundamental differences between the U.S. and E.U. regulatory requirements; and\nGain insights into what you need to know for importing and exporting homeopathic drugs between the U.S. and E.U.\n\nThis one-hour webinar will introduce your company to the myriad of aspects every company needs to consider in today’s international marketplace. Presented by two established experts in the field\, this webinar will provide companies with the framework to understand the differences and comparisons between the U.S. and E.U. regulatory requirements\, as well as the impact of “the other” on your company’s suppliers and markets. The webinar will also provide an awareness of the differences between the various national pharmacopeias and why an ignorance of “the other” can lead to your products being deemed as misbranded or adulterated. \n\n	\n\n\n	\n		\n	Presenters\nSteve Mann\, Director of External Global Regulatory Affairs & QPPV\, Nelsons\n\nSteve has worked with Nelsons for more than 15 years with 20 years experience in the field of global regulation for homoeopathic drugs\, cosmetics\, herbal and dietary supplements\, and medical devices. He has worked on and managed regulatory and compliance projects in North\, Central and South America\, Europe\, North and East Africa\, Asia\, and Australasia. \nSteve currently holds board positions with various industry trade bodies\, including the British Association of Homeopathic Manufacturers (BAHM)\, the European Coalition on Homeopathic and Anthroposophic Medicinal Products (ECHAMP)\, and the U.K. Health Food Manufacturers Association (HFMA). He is also a Member of the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) and sits on the Standards and Controls and Monograph Review Committees\, and the Council on Pharmacy. \nEric Foxman\, Consultant and Board Member\, HPCUS\nEric has a rich history of work in the homeopathic industry. He has been a member of the Homeopathic Pharmacopeia Convention of the United States since its founding in 1980 and is presently in his 12th year on the Board of Trustees. Eric serves as the Senior Scientist of the Convention and the Chair of the Council on Pharmacy. In these capacities\, Eric is very active in the on-going revision and updating of the contents of the HPUS. \nEric has been active a member or representative of the American Association of Homeopathic Pharmacists for over 38 years. He has presented numerous workshops on legal\, regulatory and technical aspects of the manufacturing and marketing of homeopathic drug products. He also presents updates to the HPUS through an annual webinar. Eric is a consultant to the homeopathic industry with a focus on helping companies achieve compliance with the myriad of regulatory requirements for companies’ high-quality\, well-formulated homeopathic drug products. \n\n	\n\n\n	\n		\n	Who Should Attend?\n\nAmerican companies purchasing homeopathic materials from Europe\nEuropean companies shipping homeopathic materials into the U.S.\nAmerican companies exporting or interested in exporting homeopathic products to Europe\nEuropean companies importing American homeopathic products\nCompliance managers\nPurchasing managers\nQuality managers\nThose responsible for import/export\n\n\n	\n\n\n	\n		\n	Cost\nNonmembers: $239\nAAHP Members: $149 (With $90 discount available from the AAHP office) \n  \n\n	\n\n\n	\n		\n	\n		Register Today!\n		\n	\n	\n		\n			\n							Click Here to Register
URL:https://theaahp.org/event/the-homeopathic-market-analytical-tools-for-understanding-and-growth-webinar-archive/
LOCATION:Webinar Archive
CATEGORIES:Webinar,Webinar Archive
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20150106
DTEND;VALUE=DATE:20180106
DTSTAMP:20260625T152947
CREATED:20140127T200856Z
LAST-MODIFIED:20150123T182821Z
UID:10000057-1420502400-1515196799@theaahp.org
SUMMARY:How To Survive a Product Recall Webinar Archive
DESCRIPTION:11:00 a.m. ET • 10:00 a.m. CT • 9:00 a.m. MT • 8:00 a.m. PT • 16.00 GMT • 17.00 CET \n\n	\n\n\n\n	\n		\n	\n\n\n	\n						\n		\n\n			\n	\n	\n		\n	Summary\nWhether your company is located in the U.S. or the E.U.\, you need to be aware of regulations on “the other” side of the ocean in today’s global market. This is especially true for homeopathic drugs\, the starting materials for many of which are available only from one continent or the other. \nHow do the regulations within the supplier’s country impact your ability to import those starting materials? What are the ramifications of the end marketer’s national requirements on the export of homeopathic starting materials? \nAttend this important and timely webinar to: \n\nReceive an overview of the regulatory frameworks for homeopathic drugs in the U.S. and E.U.;\nUnderstand the fundamental differences between the U.S. and E.U. regulatory requirements; and\nGain insights into what you need to know for importing and exporting homeopathic drugs between the U.S. and E.U.\n\nThis one-hour webinar will introduce your company to the myriad of aspects every company needs to consider in today’s international marketplace. Presented by two established experts in the field\, this webinar will provide companies with the framework to understand the differences and comparisons between the U.S. and E.U. regulatory requirements\, as well as the impact of “the other” on your company’s suppliers and markets. The webinar will also provide an awareness of the differences between the various national pharmacopeias and why an ignorance of “the other” can lead to your products being deemed as misbranded or adulterated. \n\n	\n\n\n	\n		\n	Presenters\nSteve Mann\, Director of External Global Regulatory Affairs & QPPV\, Nelsons\n\nSteve has worked with Nelsons for more than 15 years with 20 years experience in the field of global regulation for homoeopathic drugs\, cosmetics\, herbal and dietary supplements\, and medical devices. He has worked on and managed regulatory and compliance projects in North\, Central and South America\, Europe\, North and East Africa\, Asia\, and Australasia. \nSteve currently holds board positions with various industry trade bodies\, including the British Association of Homeopathic Manufacturers (BAHM)\, the European Coalition on Homeopathic and Anthroposophic Medicinal Products (ECHAMP)\, and the U.K. Health Food Manufacturers Association (HFMA). He is also a Member of the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) and sits on the Standards and Controls and Monograph Review Committees\, and the Council on Pharmacy. \nEric Foxman\, Consultant and Board Member\, HPCUS\nEric has a rich history of work in the homeopathic industry. He has been a member of the Homeopathic Pharmacopeia Convention of the United States since its founding in 1980 and is presently in his 12th year on the Board of Trustees. Eric serves as the Senior Scientist of the Convention and the Chair of the Council on Pharmacy. In these capacities\, Eric is very active in the on-going revision and updating of the contents of the HPUS. \nEric has been active a member or representative of the American Association of Homeopathic Pharmacists for over 38 years. He has presented numerous workshops on legal\, regulatory and technical aspects of the manufacturing and marketing of homeopathic drug products. He also presents updates to the HPUS through an annual webinar. Eric is a consultant to the homeopathic industry with a focus on helping companies achieve compliance with the myriad of regulatory requirements for companies’ high-quality\, well-formulated homeopathic drug products. \n\n	\n\n\n	\n		\n	Who Should Attend?\n\nAmerican companies purchasing homeopathic materials from Europe\nEuropean companies shipping homeopathic materials into the U.S.\nAmerican companies exporting or interested in exporting homeopathic products to Europe\nEuropean companies importing American homeopathic products\nCompliance managers\nPurchasing managers\nQuality managers\nThose responsible for import/export\n\n\n	\n\n\n	\n		\n	Cost\nNonmembers: $239\nAAHP Members: $149 (With $90 discount available from the AAHP office) \n  \n\n	\n\n\n	\n		\n	\n		Register Today!\n		\n	\n	\n		\n			\n							Click Here to Register
URL:https://theaahp.org/event/how-to-survive-a-product-recall/
LOCATION:Webinar Archive
CATEGORIES:Webinar,Webinar Archive
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20150105
DTEND;VALUE=DATE:20180105
DTSTAMP:20260625T152947
CREATED:20140127T200313Z
LAST-MODIFIED:20150123T182729Z
UID:10000058-1420416000-1515110399@theaahp.org
SUMMARY:FDA Hot Topics - Webinar Archive
DESCRIPTION:11:00 a.m. ET • 10:00 a.m. CT • 9:00 a.m. MT • 8:00 a.m. PT • 16.00 GMT • 17.00 CET \n\n	\n\n\n\n	\n		\n	\n\n\n	\n						\n		\n\n			\n	\n	\n		\n	Summary\nWhether your company is located in the U.S. or the E.U.\, you need to be aware of regulations on “the other” side of the ocean in today’s global market. This is especially true for homeopathic drugs\, the starting materials for many of which are available only from one continent or the other. \nHow do the regulations within the supplier’s country impact your ability to import those starting materials? What are the ramifications of the end marketer’s national requirements on the export of homeopathic starting materials? \nAttend this important and timely webinar to: \n\nReceive an overview of the regulatory frameworks for homeopathic drugs in the U.S. and E.U.;\nUnderstand the fundamental differences between the U.S. and E.U. regulatory requirements; and\nGain insights into what you need to know for importing and exporting homeopathic drugs between the U.S. and E.U.\n\nThis one-hour webinar will introduce your company to the myriad of aspects every company needs to consider in today’s international marketplace. Presented by two established experts in the field\, this webinar will provide companies with the framework to understand the differences and comparisons between the U.S. and E.U. regulatory requirements\, as well as the impact of “the other” on your company’s suppliers and markets. The webinar will also provide an awareness of the differences between the various national pharmacopeias and why an ignorance of “the other” can lead to your products being deemed as misbranded or adulterated. \n\n	\n\n\n	\n		\n	Presenters\nSteve Mann\, Director of External Global Regulatory Affairs & QPPV\, Nelsons\n\nSteve has worked with Nelsons for more than 15 years with 20 years experience in the field of global regulation for homoeopathic drugs\, cosmetics\, herbal and dietary supplements\, and medical devices. He has worked on and managed regulatory and compliance projects in North\, Central and South America\, Europe\, North and East Africa\, Asia\, and Australasia. \nSteve currently holds board positions with various industry trade bodies\, including the British Association of Homeopathic Manufacturers (BAHM)\, the European Coalition on Homeopathic and Anthroposophic Medicinal Products (ECHAMP)\, and the U.K. Health Food Manufacturers Association (HFMA). He is also a Member of the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) and sits on the Standards and Controls and Monograph Review Committees\, and the Council on Pharmacy. \nEric Foxman\, Consultant and Board Member\, HPCUS\nEric has a rich history of work in the homeopathic industry. He has been a member of the Homeopathic Pharmacopeia Convention of the United States since its founding in 1980 and is presently in his 12th year on the Board of Trustees. Eric serves as the Senior Scientist of the Convention and the Chair of the Council on Pharmacy. In these capacities\, Eric is very active in the on-going revision and updating of the contents of the HPUS. \nEric has been active a member or representative of the American Association of Homeopathic Pharmacists for over 38 years. He has presented numerous workshops on legal\, regulatory and technical aspects of the manufacturing and marketing of homeopathic drug products. He also presents updates to the HPUS through an annual webinar. Eric is a consultant to the homeopathic industry with a focus on helping companies achieve compliance with the myriad of regulatory requirements for companies’ high-quality\, well-formulated homeopathic drug products. \n\n	\n\n\n	\n		\n	Who Should Attend?\n\nAmerican companies purchasing homeopathic materials from Europe\nEuropean companies shipping homeopathic materials into the U.S.\nAmerican companies exporting or interested in exporting homeopathic products to Europe\nEuropean companies importing American homeopathic products\nCompliance managers\nPurchasing managers\nQuality managers\nThose responsible for import/export\n\n\n	\n\n\n	\n		\n	Cost\nNonmembers: $239\nAAHP Members: $149 (With $90 discount available from the AAHP office) \n  \n\n	\n\n\n	\n		\n	\n		Register Today!\n		\n	\n	\n		\n			\n							Click Here to Register
URL:https://theaahp.org/event/fda-current-hot-topics/
LOCATION:Webinar Archive
CATEGORIES:Webinar,Webinar Archive
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20150104
DTEND;VALUE=DATE:20180105
DTSTAMP:20260625T152947
CREATED:20140604T182228Z
LAST-MODIFIED:20150123T182402Z
UID:10000052-1420329600-1515110399@theaahp.org
SUMMARY:Homeopathic Market – Consumer Trends and Insights Webinar Archive
DESCRIPTION:11:00 a.m. ET • 10:00 a.m. CT • 9:00 a.m. MT • 8:00 a.m. PT • 16.00 GMT • 17.00 CET \n\n	\n\n\n\n	\n		\n	\n\n\n	\n						\n		\n\n			\n	\n	\n		\n	Summary\nWhether your company is located in the U.S. or the E.U.\, you need to be aware of regulations on “the other” side of the ocean in today’s global market. This is especially true for homeopathic drugs\, the starting materials for many of which are available only from one continent or the other. \nHow do the regulations within the supplier’s country impact your ability to import those starting materials? What are the ramifications of the end marketer’s national requirements on the export of homeopathic starting materials? \nAttend this important and timely webinar to: \n\nReceive an overview of the regulatory frameworks for homeopathic drugs in the U.S. and E.U.;\nUnderstand the fundamental differences between the U.S. and E.U. regulatory requirements; and\nGain insights into what you need to know for importing and exporting homeopathic drugs between the U.S. and E.U.\n\nThis one-hour webinar will introduce your company to the myriad of aspects every company needs to consider in today’s international marketplace. Presented by two established experts in the field\, this webinar will provide companies with the framework to understand the differences and comparisons between the U.S. and E.U. regulatory requirements\, as well as the impact of “the other” on your company’s suppliers and markets. The webinar will also provide an awareness of the differences between the various national pharmacopeias and why an ignorance of “the other” can lead to your products being deemed as misbranded or adulterated. \n\n	\n\n\n	\n		\n	Presenters\nSteve Mann\, Director of External Global Regulatory Affairs & QPPV\, Nelsons\n\nSteve has worked with Nelsons for more than 15 years with 20 years experience in the field of global regulation for homoeopathic drugs\, cosmetics\, herbal and dietary supplements\, and medical devices. He has worked on and managed regulatory and compliance projects in North\, Central and South America\, Europe\, North and East Africa\, Asia\, and Australasia. \nSteve currently holds board positions with various industry trade bodies\, including the British Association of Homeopathic Manufacturers (BAHM)\, the European Coalition on Homeopathic and Anthroposophic Medicinal Products (ECHAMP)\, and the U.K. Health Food Manufacturers Association (HFMA). He is also a Member of the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) and sits on the Standards and Controls and Monograph Review Committees\, and the Council on Pharmacy. \nEric Foxman\, Consultant and Board Member\, HPCUS\nEric has a rich history of work in the homeopathic industry. He has been a member of the Homeopathic Pharmacopeia Convention of the United States since its founding in 1980 and is presently in his 12th year on the Board of Trustees. Eric serves as the Senior Scientist of the Convention and the Chair of the Council on Pharmacy. In these capacities\, Eric is very active in the on-going revision and updating of the contents of the HPUS. \nEric has been active a member or representative of the American Association of Homeopathic Pharmacists for over 38 years. He has presented numerous workshops on legal\, regulatory and technical aspects of the manufacturing and marketing of homeopathic drug products. He also presents updates to the HPUS through an annual webinar. Eric is a consultant to the homeopathic industry with a focus on helping companies achieve compliance with the myriad of regulatory requirements for companies’ high-quality\, well-formulated homeopathic drug products. \n\n	\n\n\n	\n		\n	Who Should Attend?\n\nAmerican companies purchasing homeopathic materials from Europe\nEuropean companies shipping homeopathic materials into the U.S.\nAmerican companies exporting or interested in exporting homeopathic products to Europe\nEuropean companies importing American homeopathic products\nCompliance managers\nPurchasing managers\nQuality managers\nThose responsible for import/export\n\n\n	\n\n\n	\n		\n	Cost\nNonmembers: $239\nAAHP Members: $149 (With $90 discount available from the AAHP office) \n  \n\n	\n\n\n	\n		\n	\n		Register Today!\n		\n	\n	\n		\n			\n							Click Here to Register
URL:https://theaahp.org/event/homeopathic-market-webinar-on-consumer-trends-and-insights/
LOCATION:Webinar Archive
CATEGORIES:Webinar,Webinar Archive
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20150103
DTEND;VALUE=DATE:20180103
DTSTAMP:20260625T152947
CREATED:20140127T203828Z
LAST-MODIFIED:20150123T182654Z
UID:10000074-1420243200-1514937599@theaahp.org
SUMMARY:Homeopathic Pharmacopeia -- 2013 Updates: What Might Affect Your Business Webinar Archive
DESCRIPTION:11:00 a.m. ET • 10:00 a.m. CT • 9:00 a.m. MT • 8:00 a.m. PT • 16.00 GMT • 17.00 CET \n\n	\n\n\n\n	\n		\n	\n\n\n	\n						\n		\n\n			\n	\n	\n		\n	Summary\nWhether your company is located in the U.S. or the E.U.\, you need to be aware of regulations on “the other” side of the ocean in today’s global market. This is especially true for homeopathic drugs\, the starting materials for many of which are available only from one continent or the other. \nHow do the regulations within the supplier’s country impact your ability to import those starting materials? What are the ramifications of the end marketer’s national requirements on the export of homeopathic starting materials? \nAttend this important and timely webinar to: \n\nReceive an overview of the regulatory frameworks for homeopathic drugs in the U.S. and E.U.;\nUnderstand the fundamental differences between the U.S. and E.U. regulatory requirements; and\nGain insights into what you need to know for importing and exporting homeopathic drugs between the U.S. and E.U.\n\nThis one-hour webinar will introduce your company to the myriad of aspects every company needs to consider in today’s international marketplace. Presented by two established experts in the field\, this webinar will provide companies with the framework to understand the differences and comparisons between the U.S. and E.U. regulatory requirements\, as well as the impact of “the other” on your company’s suppliers and markets. The webinar will also provide an awareness of the differences between the various national pharmacopeias and why an ignorance of “the other” can lead to your products being deemed as misbranded or adulterated. \n\n	\n\n\n	\n		\n	Presenters\nSteve Mann\, Director of External Global Regulatory Affairs & QPPV\, Nelsons\n\nSteve has worked with Nelsons for more than 15 years with 20 years experience in the field of global regulation for homoeopathic drugs\, cosmetics\, herbal and dietary supplements\, and medical devices. He has worked on and managed regulatory and compliance projects in North\, Central and South America\, Europe\, North and East Africa\, Asia\, and Australasia. \nSteve currently holds board positions with various industry trade bodies\, including the British Association of Homeopathic Manufacturers (BAHM)\, the European Coalition on Homeopathic and Anthroposophic Medicinal Products (ECHAMP)\, and the U.K. Health Food Manufacturers Association (HFMA). He is also a Member of the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) and sits on the Standards and Controls and Monograph Review Committees\, and the Council on Pharmacy. \nEric Foxman\, Consultant and Board Member\, HPCUS\nEric has a rich history of work in the homeopathic industry. He has been a member of the Homeopathic Pharmacopeia Convention of the United States since its founding in 1980 and is presently in his 12th year on the Board of Trustees. Eric serves as the Senior Scientist of the Convention and the Chair of the Council on Pharmacy. In these capacities\, Eric is very active in the on-going revision and updating of the contents of the HPUS. \nEric has been active a member or representative of the American Association of Homeopathic Pharmacists for over 38 years. He has presented numerous workshops on legal\, regulatory and technical aspects of the manufacturing and marketing of homeopathic drug products. He also presents updates to the HPUS through an annual webinar. Eric is a consultant to the homeopathic industry with a focus on helping companies achieve compliance with the myriad of regulatory requirements for companies’ high-quality\, well-formulated homeopathic drug products. \n\n	\n\n\n	\n		\n	Who Should Attend?\n\nAmerican companies purchasing homeopathic materials from Europe\nEuropean companies shipping homeopathic materials into the U.S.\nAmerican companies exporting or interested in exporting homeopathic products to Europe\nEuropean companies importing American homeopathic products\nCompliance managers\nPurchasing managers\nQuality managers\nThose responsible for import/export\n\n\n	\n\n\n	\n		\n	Cost\nNonmembers: $239\nAAHP Members: $149 (With $90 discount available from the AAHP office) \n  \n\n	\n\n\n	\n		\n	\n		Register Today!\n		\n	\n	\n		\n			\n							Click Here to Register
URL:https://theaahp.org/event/homeopathic-pharmacopeia-updates-what-changes-might-affect-your-business/
LOCATION:Webinar Archive
CATEGORIES:Webinar,Webinar Archive
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20150102
DTEND;VALUE=DATE:20180103
DTSTAMP:20260625T152947
CREATED:20140127T195420Z
LAST-MODIFIED:20150123T182616Z
UID:10000061-1420156800-1514937599@theaahp.org
SUMMARY:Homeopathic Labeling: The FDA Is Watching - Webinar Archive
DESCRIPTION:11:00 a.m. ET • 10:00 a.m. CT • 9:00 a.m. MT • 8:00 a.m. PT • 16.00 GMT • 17.00 CET \n\n	\n\n\n\n	\n		\n	\n\n\n	\n						\n		\n\n			\n	\n	\n		\n	Summary\nWhether your company is located in the U.S. or the E.U.\, you need to be aware of regulations on “the other” side of the ocean in today’s global market. This is especially true for homeopathic drugs\, the starting materials for many of which are available only from one continent or the other. \nHow do the regulations within the supplier’s country impact your ability to import those starting materials? What are the ramifications of the end marketer’s national requirements on the export of homeopathic starting materials? \nAttend this important and timely webinar to: \n\nReceive an overview of the regulatory frameworks for homeopathic drugs in the U.S. and E.U.;\nUnderstand the fundamental differences between the U.S. and E.U. regulatory requirements; and\nGain insights into what you need to know for importing and exporting homeopathic drugs between the U.S. and E.U.\n\nThis one-hour webinar will introduce your company to the myriad of aspects every company needs to consider in today’s international marketplace. Presented by two established experts in the field\, this webinar will provide companies with the framework to understand the differences and comparisons between the U.S. and E.U. regulatory requirements\, as well as the impact of “the other” on your company’s suppliers and markets. The webinar will also provide an awareness of the differences between the various national pharmacopeias and why an ignorance of “the other” can lead to your products being deemed as misbranded or adulterated. \n\n	\n\n\n	\n		\n	Presenters\nSteve Mann\, Director of External Global Regulatory Affairs & QPPV\, Nelsons\n\nSteve has worked with Nelsons for more than 15 years with 20 years experience in the field of global regulation for homoeopathic drugs\, cosmetics\, herbal and dietary supplements\, and medical devices. He has worked on and managed regulatory and compliance projects in North\, Central and South America\, Europe\, North and East Africa\, Asia\, and Australasia. \nSteve currently holds board positions with various industry trade bodies\, including the British Association of Homeopathic Manufacturers (BAHM)\, the European Coalition on Homeopathic and Anthroposophic Medicinal Products (ECHAMP)\, and the U.K. Health Food Manufacturers Association (HFMA). He is also a Member of the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) and sits on the Standards and Controls and Monograph Review Committees\, and the Council on Pharmacy. \nEric Foxman\, Consultant and Board Member\, HPCUS\nEric has a rich history of work in the homeopathic industry. He has been a member of the Homeopathic Pharmacopeia Convention of the United States since its founding in 1980 and is presently in his 12th year on the Board of Trustees. Eric serves as the Senior Scientist of the Convention and the Chair of the Council on Pharmacy. In these capacities\, Eric is very active in the on-going revision and updating of the contents of the HPUS. \nEric has been active a member or representative of the American Association of Homeopathic Pharmacists for over 38 years. He has presented numerous workshops on legal\, regulatory and technical aspects of the manufacturing and marketing of homeopathic drug products. He also presents updates to the HPUS through an annual webinar. Eric is a consultant to the homeopathic industry with a focus on helping companies achieve compliance with the myriad of regulatory requirements for companies’ high-quality\, well-formulated homeopathic drug products. \n\n	\n\n\n	\n		\n	Who Should Attend?\n\nAmerican companies purchasing homeopathic materials from Europe\nEuropean companies shipping homeopathic materials into the U.S.\nAmerican companies exporting or interested in exporting homeopathic products to Europe\nEuropean companies importing American homeopathic products\nCompliance managers\nPurchasing managers\nQuality managers\nThose responsible for import/export\n\n\n	\n\n\n	\n		\n	Cost\nNonmembers: $239\nAAHP Members: $149 (With $90 discount available from the AAHP office) \n  \n\n	\n\n\n	\n		\n	\n		Register Today!\n		\n	\n	\n		\n			\n							Click Here to Register
URL:https://theaahp.org/event/homeopathic-labeling-the-fda-is-watching/
LOCATION:Webinar Archive
CATEGORIES:Webinar,Webinar Archive
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20150101
DTEND;VALUE=DATE:20180102
DTSTAMP:20260625T152947
CREATED:20140604T182631Z
LAST-MODIFIED:20150123T182455Z
UID:10000051-1420070400-1514851199@theaahp.org
SUMMARY:Homeopathic Pharmacopeia – 2014 Updates – Is Your Company Ready?  Webinar Archive
DESCRIPTION:11:00 a.m. ET • 10:00 a.m. CT • 9:00 a.m. MT • 8:00 a.m. PT • 16.00 GMT • 17.00 CET \n\n	\n\n\n\n	\n		\n	\n\n\n	\n						\n		\n\n			\n	\n	\n		\n	Summary\nWhether your company is located in the U.S. or the E.U.\, you need to be aware of regulations on “the other” side of the ocean in today’s global market. This is especially true for homeopathic drugs\, the starting materials for many of which are available only from one continent or the other. \nHow do the regulations within the supplier’s country impact your ability to import those starting materials? What are the ramifications of the end marketer’s national requirements on the export of homeopathic starting materials? \nAttend this important and timely webinar to: \n\nReceive an overview of the regulatory frameworks for homeopathic drugs in the U.S. and E.U.;\nUnderstand the fundamental differences between the U.S. and E.U. regulatory requirements; and\nGain insights into what you need to know for importing and exporting homeopathic drugs between the U.S. and E.U.\n\nThis one-hour webinar will introduce your company to the myriad of aspects every company needs to consider in today’s international marketplace. Presented by two established experts in the field\, this webinar will provide companies with the framework to understand the differences and comparisons between the U.S. and E.U. regulatory requirements\, as well as the impact of “the other” on your company’s suppliers and markets. The webinar will also provide an awareness of the differences between the various national pharmacopeias and why an ignorance of “the other” can lead to your products being deemed as misbranded or adulterated. \n\n	\n\n\n	\n		\n	Presenters\nSteve Mann\, Director of External Global Regulatory Affairs & QPPV\, Nelsons\n\nSteve has worked with Nelsons for more than 15 years with 20 years experience in the field of global regulation for homoeopathic drugs\, cosmetics\, herbal and dietary supplements\, and medical devices. He has worked on and managed regulatory and compliance projects in North\, Central and South America\, Europe\, North and East Africa\, Asia\, and Australasia. \nSteve currently holds board positions with various industry trade bodies\, including the British Association of Homeopathic Manufacturers (BAHM)\, the European Coalition on Homeopathic and Anthroposophic Medicinal Products (ECHAMP)\, and the U.K. Health Food Manufacturers Association (HFMA). He is also a Member of the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) and sits on the Standards and Controls and Monograph Review Committees\, and the Council on Pharmacy. \nEric Foxman\, Consultant and Board Member\, HPCUS\nEric has a rich history of work in the homeopathic industry. He has been a member of the Homeopathic Pharmacopeia Convention of the United States since its founding in 1980 and is presently in his 12th year on the Board of Trustees. Eric serves as the Senior Scientist of the Convention and the Chair of the Council on Pharmacy. In these capacities\, Eric is very active in the on-going revision and updating of the contents of the HPUS. \nEric has been active a member or representative of the American Association of Homeopathic Pharmacists for over 38 years. He has presented numerous workshops on legal\, regulatory and technical aspects of the manufacturing and marketing of homeopathic drug products. He also presents updates to the HPUS through an annual webinar. Eric is a consultant to the homeopathic industry with a focus on helping companies achieve compliance with the myriad of regulatory requirements for companies’ high-quality\, well-formulated homeopathic drug products. \n\n	\n\n\n	\n		\n	Who Should Attend?\n\nAmerican companies purchasing homeopathic materials from Europe\nEuropean companies shipping homeopathic materials into the U.S.\nAmerican companies exporting or interested in exporting homeopathic products to Europe\nEuropean companies importing American homeopathic products\nCompliance managers\nPurchasing managers\nQuality managers\nThose responsible for import/export\n\n\n	\n\n\n	\n		\n	Cost\nNonmembers: $239\nAAHP Members: $149 (With $90 discount available from the AAHP office) \n  \n\n	\n\n\n	\n		\n	\n		Register Today!\n		\n	\n	\n		\n			\n							Click Here to Register
URL:https://theaahp.org/event/homeopathic-pharmacopeia-a-new-round-of-updates-is-your-company-ready/
LOCATION:Webinar Archive
CATEGORIES:Webinar,Webinar Archive
END:VEVENT
END:VCALENDAR